Market revenue in 2023 | USD 351.9 million |
Market revenue in 2030 | USD 489.6 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Purity>98% |
Fastest growing segment | Purity>98% |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Purity>98%, Purity<98% |
Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.45% in 2023. Horizon Databook has segmented the Germany crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
Paracetamol is a widely consumed drug for pain treatment. However, OTC medications, such as paracetamol, are not commonly available in German drugstores or supermarkets. According to German law, only pharmacies can sell OTC or nonprescription drugs in Germany, with few exceptions.
The market growth in the country can be attributed to the high prices associated with drugs. In Germany, pharmacies have complete pricing freedom, contributing to the high price of pain relievers. The healthcare expenditure in Germany is considered the highest in Europe, accounting for 12.7% of the country’s GDP in 2022, according to the OECD Health Statistics 2023.
Moreover, well-established healthcare infrastructure and increasing government initiatives to improve healthcare facilities facilitate market growth. Germany has a large number of institutes & universities actively promoting the adoption of various drugs, boosting revenue generation.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany crocin market , including forecasts for subscribers. This country databook contains high-level insights into Germany crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account